Atlas Trials

A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus

Clinical trial NCT01655186 · WITHDRAWN

Trial details

NCT number
NCT01655186
Sponsor
Biogen
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Start date
2012-09-30
Primary completion
2012-10-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.